Skip to main content

Table 1 Baseline characteristics of the population for type 2 diabetes mellitus incidence study

From: Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study

 

Incident-DIAB

Non-DIAB

P-value

n

107

355

n/a

Men/women (n)

87/20

302/53

n/a

Age (years)

58.75 ± 0.87

57.33 ± 0.50

0.171

Weight (kg)

85.70 ± 1.47

82.49 ± 0.72

0.037

BMI (kg/m2)

31.39 ± 0.47

29.88 ± 0.22

0.002

Waist circumference (cm)

105.28 ± 1.08

101.73 ± 0.57

0.003

Serum triacylglycerols (mg/dL)

132.60 ± 6.60

119.45 ± 3.24

0.059

Total cholesterol (mg/dL)

164.97 ± 3.41

160.65 ± 1.62

0.217

HDL-cholesterol (mg/dL)

43.52 ± 1.04

44.58 ± 0.53

0.355

LDL-cholesterol (mg/dL)

93.40 ± 2.66

91.10 ± 1.33

0.421

CRP (mg/L)

2.88 ± 0.29

2.51 ± 0.17

0.329

HbA1c (%)

6.03 ± 0.03

5.86 ± 0.02

 < 0.001

HbA1c (mmol/mol)

42.37 ± 0.36

40.51 ± 0.19

 < 0.001

Fasting glucose (mg/dL)

96.18 ± 1.04

92.59 ± 0.53

0.002

Fasting insulin (mU/L)

10.51 ± 0.66

8.34 ± 0.31

0.001

ISI

3.35 ± 0.20

4.32 ± 0.14

0.001

HOMA-IR

3.37 ± 0.30

2.58 ± 0.09

0.001

IGI

0.64 ± 0.30

1.08 ± 0.06

0.025

Disposition Index

0.83 ± 0.05

1.03 ± 0.03

0.003

  1. Means values ± S.E.M
  2. Incident-DIAB: non-diabetic patients at baseline who developed T2DM after a median follow-up of 60 months; non-DIAB: non-diabetic patients at baseline who did not develop T2DM after a median follow-up of 60 months; BMI: body mass index; HbA1c: glycated hemoglobin A1c; ISI: insulin sensitivity index; IGI: insulinogenic index
  3. One-way ANOVA P-values